In subjects with NAFLD, insulin resistance is associated with hyperinsulinemia, hyperglycemia, high plasma free fatty acid, and low plasma adiponectin levels. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.